Objectives: Surgical site infections (SSIs) after bypass procedures provoke major costs. The aim of this prospective randomised trial was to assess if preoperative duplex vein mapping (DVM) reduces costs generated by SSI. Materials/methods: Patients undergoing primary infrainguinal bypass were randomised to DVM of the ipsilateral greater saphenous vein (group A) or none (group B). Costs were calculated by the hospital's accounting department. Results: From December 2009 to April 2011, 130 patients (65 each group) were enrolled. Both cohorts were equal regarding demographics, risk factors and costs for primary bypass surgery, respectively. SSIs were classified minor (A: n ¼ 13 vs. B: n ¼ 13, P ¼ n.s.) and major (A: n ¼ 1 vs. B: n ¼ 12, P ¼ .0154). Preoperative DVM was the only significant factor to prevent major SSI (P ¼ .011). Theatre costs for SSI: A: 537 V versus B 6553 V (P ¼ .16). Recovery room/intensive care unit (ICU) costs for SSI: A: 0 V versus B: 8016 V (P ¼ .22). Surgical ward costs for SSI: A: 2823 V versus B: 22 386 V (P ¼ .011). Costs for outpatient visits due to SSI: A: 6265 V versus B: 12 831 V (P ¼ .67). Total costs of patients without SSI: 8177 V versus major SSI: 10 963 V (P < .001). Conclusion: DVM significantly reduces costs generated by re-admission in patients suffering from major SSI. Ó
The main cause for increased costs in vascular surgery are surgical site infections (SSIs), which may lead to extended hospital stay, revision surgery, prolonged antibiotic treatment and increased frequency of outpatient visits, respectively. 1, 2 SSIs are reported in up to 43% after arterial reconstructions. 3 In the 1980s, duplex vein mapping (DVM) of the greater saphenous vein (GSV) was described as a preoperative diagnostic adjunct to gain information about anatomy and graft suitability in patients undergoing infrainguinal bypass surgery. 4, 5 Further studies, all of which failed level-1 evidence, revealed that preoperative DVM of the ipsilateral GSV alleviates vein harvest and may reduce SSI after bypass procedures of the lower extremity. 6e9 The aim of this prospective randomised study was to evaluate if preoperative DVM is able to lower costs significantly by decreasing postoperative SSI.
Materials and Methods

Patients
From December 2009 until April 2011, all patients who were planned for primary infrainguinal bypass surgery underwent evaluation for inclusion into this study. Patient data were registered prospectively in a designated vascular database at a universitybased tertiary care centre. Inclusion criteria were severe claudication and critical leg ischaemia 10 as well as patients with popliteal aneurysms. After written informed consent was provided, patients were randomly allocated to two groups: group A patients underwent preoperative DVM of the ipsilateral GSV and group B did not. SSIs were classified according to the American College of Surgeon's National Surgical Quality Improvement Program (ACS-NSQIP) as superficial or deep. 11 If oral antibiotics and topical treatment were sufficient, SSIs were regarded as minor. If intravenous antibiotic therapy and/or redo surgery (debridement, etc.) were necessary, SSIs were considered as major. In cases of primary ischaemic/ gangrenous lesions of the leg and/or postoperative SSI, samples for bacterial culture were taken from the affected site. Primary study 'end' points were: length of hospital stay (LOS), duration of operative procedure, development of postoperative SSI, costs due to readmissions for SSI and costs due to outpatient visits for SSI, respectively. Secondary 'end' points were bypass patency, limb salvage and patient survival. Standard reporting guidelines were applied. 12 The study was approved by the Local Ethics Research Committee. Preliminary data regarding clinical outcome in smaller patient cohort were presented at the SVS in Chicago 2011.
Preoperative work-up, DVM and angiography
General work-up was identical for all patients and included physical examination, cardiac testing, carotid duplex, pulmonary evaluation upon the discretion of the attending cardiologist and laboratory testing including screening for hepatitis and human immunodeficiency virus (HIV).
Preoperative colour-flow duplex scanning (DS) of the ipsilateral GSV was performed in the vascular laboratory by three senior surgeons (KL, EB and AU) using a 13-MHz probe (GE Healthcare LOGIQ 7, Milwaukee, WI, USA) with the patient in supine position. After measuring venous diameter at four different levels (proximal and distal thigh, proximal and distal calf), using a high-thigh tourniquet, 13 the course of the GSV from ankle to groin and major side branches were marked with indelible dye, which was not antibacterial (e.g., gentian violet).
A vein >2.5 mm in diameter was considered as an adequate conduit in duplex mapping. This corresponded to a 3-mm distended vein bypass graft.
In all patients, assessment of distal run-off vessels was performed preoperatively. 14 The procedure was planned according to preoperative angiography.
Perioperative antibiotic regimen
Patients suffering from ischaemic ulceration or gangrene received continuous antibiotic therapy adapted to antibiogram from the day of admission. All other patients receive antibiotic prophylaxis with cefazoline 2 g intravenously at the time of induction and at 8 and 16 h postoperatively.
Bypass procedures (non-reversed, reversed, or in situ)
All patients underwent antiseptic prepping with coloured Dodesept Ò . After dissection of in-and outflow arteries, the ipsilateral GSV was harvested via multiple vertical skin incisions with intervening cutaneous bridges. Skin incisions were made with the knife, dissection of deeper layers with a cautery. In the case of nonreversed bypass, proximal valves were excised under direct vision, remaining valves lysed by valvulotome (Mill's type) introduced via the distal end of the vein. In cases of in situ bypasses, valvulotomy was performed with a flexible valvulotome (UreSil Tru-Incise, USA). In all types of bypasses, a calliper was used for intra-operative measurement of graft diameter and a ruler to measure graft length. Wound closure was performed with running single layer subcuticular sutures (Vicryl 3.0) and stainless skin staples.
The technique used for bypass surgery was at the discretion of the surgeon. Technical details have been reported previously. 15e17
Postoperative follow-up
Assessors (vascular surgeons) in the ward were not blinded to the allocated treatment. After discharge clinical examination of the study patients with measurement of ankle-brachial pressure index (ABPI) and DS of the bypass were routinely carried out at 1, 3, 6 and 12 months postoperatively. In cases of SSI, patients were seen more frequently in the outpatient department. The personnel in the outpatient department (nursing staff and physician) had no access to randomisation data and were therefore blinded to the allocated treatment.
Cost calculation
Costs were calculated by our hospital's accounting department as follows: costs for hospitalisation on the surgical ward (201.68 V/day, costs for DS included), recovery room (922.32 V/day), intensive care unit (ICU) (1702.36 V/day), usage of operating room (OR) (16.26 V/min) and outpatient visit (60.24 V/visit). Medication during hospital stay was included into cost calculation. After discharge, antibiotic treatment was excluded from cost calculation. We distinguished four different types of costs: primary costs for admission due to primary infrainguinal bypass procedure (surgical ward, OR for primary bypass procedure, recovery room, ICU and overall), secondary costs for re-admission due to SSI (surgical ward, OR for revision surgery, recovery room, ICU and overall), costs for outpatient visits and total costs (primary, secondary and outpatient visits), respectively.
Randomisation
Randomisation was carried out using sealed envelopes with the allocation to DVM (group A) or not (group B).
Statistical methods
No power analysis was done. Data were presented as means AE standard deviation (SD) and percentages. Fisher's exact and Pearson's chi-square test were used for discrete variables, and two-sided, unpaired Student's t-test for continuously distributed data. KaplaneMeier curves with 95% confidence intervals (CIs) were computed and compared using the log-rank test and Cox-F test. Relative risks and 95% CIs were computed for selected crosstabulation tables. Computations for testing and estimation of relative risks were done with MATHEMATICA 7.0. To detect independent predictors of SSIs, in a first step binary univariate logistic regression analyses were done. Those variables in the model with a P value less than 0.1 were included to build a multivariate model. Odds ratios with 95% confidence intervals are given in the multivariate model to get an impression of the magnitude of the effect. All analyses were done by using Statistica 6.1 (StatSoft, Inc. 2004. Statistica data analysis software system version 6.1), Statistical Package for Social Sciences (SPSS) 10 (SPSS, Inc., 1999, Chicago, IL, USA), and MATHEMATICA 7.1 (Wolfram Research, Inc., Mathematica, Version 7.0, Champaign, IL 2008, USA). A P value less than 5% was considered statistically significant.
Results
Patients
From December 2009 until April 2011, in 199 patients primary infrainguinal bypass surgery was planned. As many as 135 of 199 (68%) patients met inclusion criteria (Table 1) ; 64/199 (32%) patients were excluded for different reasons (Fig. 1 ). Five of 135 (4%) eligible patients refused randomisation; 130/199 (65%) patients were randomly assigned to group A (with DVM, n ¼ 65) or B (without DVM, n ¼ 65) ( Fig. 1 ). Both groups were equal regarding demographics, risk factors, surgical indication, preoperative ABPI and distal run-off, respectively (Table 1) .
Pre-and intra-operative findings of ipsilateral GSV
All mapped veins of group A patients were patent and usable for bypass. Intra-operatively measured diameters of GSV did not differ between group A and B patients at all levels (proximal thigh: P ¼ .22, distal thigh: P ¼ .36, proximal calf: P ¼ .09, distal calf: P ¼ .49).
Bypasses, bailout procedures and LOS
Femoroinfrapopliteal (distal anastomosis below the knee joint) bypasses were performed significantly more often than femoropopliteal (distal anastomosis above the knee joint) bypasses in both groups (P < .00001). Target vessels were distal popliteal artery (group A: n ¼ 11, group B: n ¼ 15), tibioperoneal trunk (A: n ¼ 3, B: n ¼ 3), anterior tibial artery (A: n ¼ 9, B: n ¼ 8), posterior tibial artery (A: n ¼ 2, B: n ¼ 5), peroneal artery (A: n ¼ 9, B: n ¼ 8), dorsalis pedis artery (A: n ¼ 10, B: n ¼ 11) and medial plantar artery (A: n ¼ 3, B: n ¼ 2). Translocated non-reversed bypass was the preferred technique followed by reversed and in situ bypass. Both groups were equal regarding operative time, incisional length and overall bypass length, respectively ( Table 2 ). In group B, the surgical strategy had to be changed in 6/65 (9.2%) patients always due to vein conduit issues (insufficient GSV diameter n ¼ 4, sclerotic GSV n ¼ 2) ( Table 2 ). In 3/6 (50%) patients the accessory saphenous vein and in 2/6 (33.3%) All patients received subcutaneous low-molecular-weight heparin postoperatively until discharge. After discharge, 18 patients in group A and 21 patients in group B received oral anticoagulation (phenprocoumon or acenocoumarol, target International normalised ratio, INR, 2e3). There was no statistically significant difference between both groups regarding postoperative anticoagulation.
Postoperative SSI and re-admissions due to SSI ( Major SSIs were significantly less common in group A (RR, .08; 95% CI, .01e.62; P ¼ .0154). Minor SSIs were equally distributed between both study groups.
Re-admissions due to SSI were seen significantly less often in group A patients (RR, .18; 95% CI, .04e.79; P ¼ .022). In group A, two patients (3.1%) were re-admitted because of SSI (one minor SSI for wound care due to poor medical attendance at home and one major SSI for surgical revision with debridement). In group B, 11 patients (16.9%) were re-admitted due to SSI (all major SSIs, six intravenous antibiotic treatment and five surgical revision with debridement). One group A patient with major SSI refused re-admission and was managed conservatively over a period of 4 months until wound complication was healed.
Mean duration of LOS at re-admission did not differ between both groups (P ¼ .7), indicating a similar severity of SSI in both groups. Two patients in group B died after re-admission due cardiac failure related to septic complications following major SSI.
Predictors of major SSI
Preoperative DVM was the only significant factor predicting the development of postoperative major SSI (odds ratio, 14.59; 95% CI, 1.8e115; P ¼ .011) ( Table 4 ).
Primary costs in 130 randomised patients
There was no significant difference regarding mean surgical ward costs for pre-(P ¼ .38) and postoperative LOS (P ¼ .86), OR costs (P ¼ .38), recovery room costs (P ¼ .12) and ICU costs (P ¼ .08), respectively, between group A and B patients ( Table 5 ).
Secondary costs
There was a significant difference between group A and B patients regarding mean secondary surgical ward costs (P ¼ .011) and overall secondary costs due to re-admission for SSI (P ¼ .008) ( Table 6 ). Secondary costs for revision surgery, recovery room and ICU were equal between group A and B patients suffering from SSI.
Costs for outpatient visits
Mean costs for outpatient visits were equal between group A and B patients (496 V vs. 363 V; P ¼ .29). Mean costs for outpatient visits in patients with SSI did not differ significantly between group A and B patients (448 V vs. 513 V; P ¼ .67).
Total costs for patients with major SSI
There was a significant difference of mean total costs between patients without SSI and patients suffering from major SSI (90 V vs. 843 V; P < .001). 
Primary and secondary costs for patients with intra-operative change of surgical strategy
Patients with intra-operative change of surgical strategy and patients without strategy change were equal regarding primary costs for preoperative LOS (P ¼ 1.0), bypass surgery (P ¼ .40), recovery room (P ¼ .87), ICU (P ¼ .69) and postoperative LOS (P ¼ .93), respectively.
Secondary costs for surgical ward (P ¼ .0008), revision surgery (P ¼ .0006), recovery room (P ¼ .0001) and ICU (P ¼ .0021) were significantly increased in patients with intra-operative change of surgical strategy compared to patients without intra-operative change ( Table 7) .
Follow-up, bypass patency, limb salvage and survival
No patient was lost to follow-up. Mean follow-up time was 7.4 AE 4.2 months and 7.3 AE 4.4 months for group A and B patients (P ¼ .83); 7/130 primary bypasses (5.4%) occluded. Two bypasses in each group failed within 30 days (30-day secondary bypass patency rates: 96.2%). Late bypass occlusions have been observed in one group A patient (6 weeks postoperatively) and in two group B patients (9 weeks and 10 weeks postoperatively), respectively. The cause for early and late bypass occlusions could not be determined.
Six minor amputations in group A and five in group B had to be performed during follow-up period. One diabetic patient in group A without SSI and with patent bypass underwent below-knee major amputation 6 months after bypass surgery because of progressive gangrene of the foot (limb salvage rate 98.5%).
Thirty day survival rates were 100% in group A and 97% in group B.
Discussion
The study showed that major SSIs provoked significantly increased total costs in patients suffering from major SSI compared to patients without SSI (P ¼ .001). Preoperative DVM and marking of the ipsilateral GSV was the only independent predictor for development of major wound complications after infrainguinal bypass surgery, which confirms the importance of DVM as a diagnostic tool prior to lower extremity revascularisation in reducing secondary in-hospital costs significantly. In-situ bypass technique was nearly significantly distributed between groups A and B (Table 2 ) and may in part explain the findings of this study.
Postoperative wound complications as a major factor for increased costs after lower extremity revascularisation are reported in the literature but detailed cost analyses are rare.
Kent et al. reported additional mean costs per patient of 688 $ due to prolonged hospitalisation, rehospitalisation, re-operation, rehabilitation and visiting nurse services caused by wound complications after lower limb revascularisation. 1 The authors concluded that costs would have been higher in cases of major wound complications, which was confirmed by our study (mean additional costs per patient due to major SSI: 1681 V in group A and 3360 V in group B). In our study, SSI did not cause a prolonged primary hospital stay, but the main difference of additional costs between both study groups was due to secondary admission for major SSI, whereas secondary costs for recovery room and ICU at re-admission were equal. Rehabilitation costs and costs for visiting nurse services were not part of our study. Costs for outpatient visits in group B patients who suffered significantly more major SSI were not different from group A patients because patients suffering from major SSI were re-admitted early for conservative or surgical treatment.
Similar to our results, a Scandinavian prospective multicentre observational study reported average costs attributable to SSI after vascular surgery of 3320 V per patient. 3 Included were costs for additional days of hospitalisation, operating department fees for reexploration and revision, visits to outpatient clinic, outpatient nursing visit and rehabilitation.
Unexpectedly, all mapped veins of group A patients were usable for bypass surgery, whereas in six group B patients (without preoperative DVM) the surgical strategy had to be changed intraoperatively due to vein conduit issues. This difference was statistically significant (P ¼ .027). On the other hand, the outcome of patients undergoing intra-operative change of surgical strategy was poor (three major SSIs, three re-admissions, two bypass occlusions and one death due to cardiac failure after sepsis). Fifty percent of these patients developed major wound complications. This could be the result of the creation of extended undermined skin flaps in search of surgical alternatives to a poor quality ipsilateral GSV. Interestingly, mean operative time was not significantly different to patients without intra-operative strategy change. Overall incisional length was considerably longer in patients with intra-operative change of surgical strategy but did not reach statistical significance compared to patients without strategy change (P ¼ .07). Regarding secondary costs, patients with intra-operative strategy change caused significantly increased expenses due to readmission for major SSI, revision operation, recovery room and ICU compared to patients without strategy change (Table 7) . Although the results of this prospective randomised study support the application of DVM and marking prior to infrainguial bypass procedure, some critical remarks have to be made.
No power analysis was made and the study was stopped after observing that there were eleven more subjects with major SSI in Group B compared to Group A. This stopping procedure is a limitation of the study and the findings might be a random high difference.
Up until now there are no precise duplex-based criteria regarding which GSV is "acceptable or usable" for infrainguinal bypass grafting. Our criteria (diameter > 2.5 mm, no signs of thrombosis or sclerosis) for an acceptable and usable vein for infrainguinal bypass grafting were based on the criteria described in the literature. 19, 20 Critics may argue that a 100% GSV "usability rate" in group A patients is not realistic and would have been lower if additional diagnostic tools such as angioscopy would have been used. On the other hand, we can report a 30-day patency rate of 96.2% and three bypass occlusions after a mean follow-up of 7.3 months in patients with preoperative DVM, which is within accepted standards.
In addition to angioscopy to verify the usability of the GSV for infrainguinal bypass procedures, some authors prefer endoscopically guided harvest of the GSV to reduce postoperative wound complications. 21e23 Neither angioscopy nor endoscopical vein harvest were part or aim of our study and the latter technique did not prove to cause a better outcome compared to preoperative DVM regarding the prevention of wound complications after infrainguinal bypass surgery. 21 
Conclusion
In the case of major wound complications after primary infrainguinal bypass surgery, the additional costs are significant and mainly caused by re-admission. Major SSIs after infrainguinal bypass surgery can be prevented by preoperative DVM and marking of the ipsilateral GSV. Therefore, this technique should be a standard preoperative diagnostic adjunct for infrainguinal bypass surgery. In the case of an intra-operative change of surgical strategy during primary infrainguinal bypass surgery, the postoperative outcome could be poor and secondary costs due to SSI significant
